DIGNITANA
Dignitana develops a patented scalp cooling system, DigniCap that reduces chemotherapy-induced hair loss. Dignitana's patented DigniCap® system has demonstrated excellent scientific results in clinical studies. More than eight out of ten treated patients were able to retain enough of their hair to eliminate the need for a wig.
DIGNITANA
Industry:
Biotechnology Life Science Manufacturing Medical
Founded:
1996-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.dignitana.se
Total Employee:
11+
Status:
Active
Contact:
556730-5346
Total Funding:
0
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Loopia DNS Loopia WordPress 4.0
Similar Organizations
Bioprocess
Bioprocess is a privately held corporation that produces and markets DNA-based technologies for biomedical sciences.
Ostell AB
Founded in 1999, Osstell manufactures and markets instruments that assess the stability of dental implants.
Current Employees Featured
Founder
Investors List
Green Park & Golf Ventures
Green Park & Golf Ventures investment in Venture Round - Dignitana
Green Park & Golf Ventures
Green Park & Golf Ventures investment in Venture Round - Dignitana
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-17 | Dignitana AB appoints Chief Financial Officer |
Official Site Inspections
http://www.dignitana.se
- Host name: 194.9.94.86
- IP address: 194.9.94.86
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Dignitana"
Company Description - Dignitana
UNITED STATES Dignitana 10925 Estate Lane, Suite 185 Dallas, TX 75238 +1 469-917-5555See details»
Investor Relations - Dignitana
Dignitana AB publicerar Årsredovisningen för 2023. LATEST FINANCIAL REPORT. 2023-08-17. Dignitana AB Q2 2023 Interim Report (English) 2024-11-21 (this item is regulatory) Dignitana …See details»
Dignitana - Crunchbase Company Profile & Funding
Dignitana develops a patented scalp cooling system, DigniCap that reduces chemotherapy-induced hair loss. Dignitana's patented DigniCap® system has demonstrated excellent scientific results in clinical studies. More than eight out …See details»
Dignitana - Crunchbase Company Profile & Funding
Organization. Dignitana . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Dignitana is a Swedish medical technology …See details»
Dignitana announces directed share issue of SEK 75 million to ...
Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries …See details»
Dignitana Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Dignitana has 5 employees across 3 locations and kr86.06 m in annual revenue in FY 2023. See insights on Dignitana including office locations, competitors, revenue, financials, …See details»
Dignitana AB Publishes Q3 2024 Interim Report (Cision) - placera.se
Nov 21, 2024 This disclosure contains information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was …See details»
Corporate Governance - Dignitana
OPERATIONS Dignitana 10925 Estate Lane, Suite 185 Dallas, TX 75238 +1 469-917-5555See details»
Dignitana’s CEO Catarina Mård Löwenadler resigns - placera.se
Apr 24, 2024 Dignitana AB announces today that Catarina Mård Löwenadler, CEO of Dignitana, after consulting with the Board of Directors, will resign as CEO on 2 May 2024, an ...See details»
Dignitana - Funding, Financials, Valuation & Investors - Crunchbase
Dignitana is registered under the ticker STO:DIGN . Dignitana is funded by 3 investors. Agartha and Swedbank Robur are the most recent investors. Unlock for free . ... How much funding …See details»
Dignitana AB (publ) appoints Nomination Committee for Annual …
Nov 18, 2024 Dignitana AB (publ) appoints Nomination Committee for Annual General Meeting 2025 The Dignitana Annual General Meeting 2025 will be held on 22 May 2025. The Nom …See details»
Leadership - Dignitana
Before coming to Dignitana, Johan Johansson worked at Additude AB supporting all stages of medical device development including medical device regulation and regulatory compliance. …See details»
Dignitana - Redeye
Aug 18, 2023 Tel. +46 8-545 013 30, E-post: [email protected] (12) per share and leave the fair value range unchanged. 6 was a bit softer than expected, we are still very confident in the long …See details»
DIGN Stock Price | Dignitana AB Stock Quote (Sweden: Stockholm ...
Nov 14, 2024 DIGN SE. Closed. Last Updated: Nov 14, 2024 6:00 p.m. CEST Delayed quote. kr 1.09-0.01-0.91%. Previous Close; kr1.10: Toggle Chart Options. ... Dignitana AB engages in …See details»
DIGN.SE | Dignitana AB Financial Statements - WSJ
Dignitana AB balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View DIGN.SE financial statements in full.See details»
Financial Reports - Dignitana
UNITED STATES Dignitana 10925 Estate Lane, Suite 185 Dallas, TX 75238 +1 469-917-5555See details»
Press Releases - Dignitana
Privacy Policy; Dignitana AB © 2024 All rights reserved.See details»
Magnus Blixt to become CEO of Dignitana AB | Placera
Jan 13, 2022 The Board of Directors of Dignitana AB has appointed Magnus Blixt as the new CEO of Dignitana. He will assume CEO responsibilities after the Annual General Meeting on …See details»
Annual Report - Dignitana
Dignitana AB (publ.) Corp. Reg. No. 556730-5346 1 (35) NOTE: This is an unofficial translation of the original report which is in Swedish. In case of discrepancies, the Swedish version shall …See details»